BAYRY•benzinga•
FDA Grants Complete Approval To Bayer's Drug For Certain Type Cancer With Mutation
Summary
Bayer's Vitrakvi receives full FDA approval based on solid tumor data showing sustained efficacy in NTRK fusion-positive patients.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 10, 2025 by benzinga